(Q34867111)

5 August 2017

1 reference

title

Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants (English)

1 reference

5 August 2017

1

Stephen M Stahl

1 reference

5 August 2017

Angela Felker

2

1 reference

5 August 2017

publication date

1 October 2008

1 reference

5 August 2017

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

855-870

1 reference

Daily transdermal administration of selegiline to guinea-pigs preferentially inhibits monoamine oxidase activity in brain when compared with intestinal and hepatic tissues

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Rasagiline in the pharmacotherapy of Parkinson's disease--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Serotonin syndrome: a complex but easily avoidable condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Extracting value from case reports: lessons from serotonin toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

High-dose selegiline in treatment-resistant older depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Transdermal selegiline and intravenous cocaine: safety and interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

A 3-year follow-up of a group of treatment-resistant depressed patients with a MAOI/tricyclic combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Understanding toxidromes: serotonin toxicity: a commentary on Montanes-Rada et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Serotonin toxicity associated with the use of linezolid: a review of postmarketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Antidepressant-like effects of selegiline in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Combining Stimulants With Monoamine Oxidase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016965

10.1017/S1092852900016965

21 January 2018

Identifiers

DOI

1 reference

release_tsfp42rmgvappk5zp7otr4a4ci

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tsfp42rmgvappk5zp7otr4a4ci

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference